Electroconvulsive Therapy and Global Policy: Why Science Must Guide Mental Health Care
When Policy and Science Diverge
Global mental health policy plays a critical role in shaping access to care. However, when policy recommendations diverge from scientific evidence, the consequences can be profound—especially for patients with severe psychiatric illness.
A recent joint statement published in The Lancet Psychiatry by leading international organizations—including the World Psychiatric Association, the American Psychiatric Association, and the European Psychiatric Association—raises serious concerns about how electroconvulsive therapy (ECT) is portrayed in the World Health Organization (WHO) ‘s recent guidance.
Why This Matters Now
The WHO’s guidance emphasizes:
- Rights-based care
- Patient autonomy
- Non-coercive practices
These are essential and widely supported principles.
However, the joint statement highlights a critical issue:
The WHO document includes scientifically inaccurate and misleading statements about ECT
Specifically, it portrays ECT as:
- Inherently dangerous
- Harmful
- A treatment that should be restricted or even prohibited
According to the authors, such portrayals risk reinforcing stigma and limiting access to life-saving treatment.
What Does the Evidence Actually Show?
The consensus from decades of research is clear:
ECT Is Effective and Life-Saving
ECT is one of the most effective treatments for:
- Severe depression
- Catatonia
- Treatment-resistant psychiatric illness
It is associated with:
- Reduced mortality and suicide risk
- High response rates, even in severe cases
ECT Is Safe and Well-Tolerated
Modern ECT:
- Does not cause brain damage
- Is associated with neuroplastic changes, including increased grey matter volume
- Does not increase the risk of dementia
Cognitive Side Effects Are Usually Transient
While side effects can occur:
- Most cognitive effects are temporary and mild to moderate
- Many patients experience overall cognitive improvement as depression improves
A Critical Ethical Question
The joint statement raises an important ethical concern:
Restricting or denying access to ECT in life-threatening situations may be unethical
This includes:
- Patients with severe suicidal depression
- Individuals with catatonia
- Patients lacking decision-making capacity
In these cases, ECT may be:
- The most effective treatment available
- Sometimes the only life-saving intervention
Special Populations: Children and Incapacitated Patients
The statement also addresses controversial but critical areas:
Children and Adolescents
- Evidence supports high response rates in severe cases
- Side effects are generally limited and transient
- ECT may be life-saving in conditions such as severe mood disorders or catatonia
Patients Without Decision-Making Capacity
- These patients often have equal or better response rates
- ECT may help restore decision-making capacity
- Denying treatment based solely on lack of consent may exclude the most vulnerable patients
The Real Risk: Stigma and Misinformation
One of the most powerful messages from this paper is:
Misinformation about ECT can directly harm patients
When ECT is misrepresented:
- Clinicians may hesitate to refer
- Patients may refuse treatment
- Health systems may restrict access
This perpetuates a cycle where:
The most effective treatment is often the least accessible
UTHealth Houston Perspective
At the Center for Interventional Psychiatry at UTHealth Houston, we strongly align with the principles outlined in this global statement:
- Commitment to evidence-based care
- Advocacy for patient access to life-saving treatments
- Emphasis on safe, modern, and ethical use of ECT
We also recognize the importance of:
- Transparency
- Informed consent
- Patient-centered care
But these principles must be balanced with:
Access to effective treatment—especially in life-threatening situations
Implications for Policy and Practice
This publication sends a clear message to policymakers:
1️. Science Must Guide Policy
Mental health policies must reflect current scientific evidence, not outdated perceptions.
2️. Avoid Unintended Harm
Restrictive policies may unintentionally:
- Increase suffering
- Prolonged illness
- Raise mortality risk
3️. Protect Access to Life-Saving Treatments
ECT should remain available:
- Across age groups (with safeguards)
- In severe and refractory cases
- Within ethical and legal frameworks
Final Thoughts
Electroconvulsive therapy remains one of the most misunderstood—and most effective—treatments in psychiatry.
This global expert statement highlights a critical reality:
The greatest risk is not the treatment itself—but the failure to provide it when needed
As psychiatry continues to evolve, we must ensure that:
- Policy aligns with science
- Stigma does not limit care
- Patients have access to the full range of effective treatments
For many individuals with severe psychiatric illness:
ECT is not a last resort—it is a life-saving intervention
Reference
Zilles-Wegner D, Wasserman D, Schulze TG, et al. Joint statement by the World Psychiatric Association, the American Psychiatric Association, the European Psychiatric Association, and the Global Expert Task Force on ECT on the portrayal of electroconvulsive therapy in WHO guidance. The Lancet Psychiatry. 2026.
Contact
Request for Second Opinion Form – https://Go.uth.edu/CIPIntake
Phone – (713) 486-2621
Fax – (713) 500-2728
E-mail – [email protected]
Website – https://go.uth.edu/CIP
Disclaimer
This article was created with the assistance of artificial intelligence (AI) to help organize and refine the presentation of scientific information. All medical and scientific content has been reviewed and approved by Joao L. de Quevedo, MD, PhD, Executive Director of the Center for Interventional Psychiatry at the John S. Dunn Behavioral Sciences Center at UTHealth Houston. The content is intended for educational and informational purposes only and does not substitute for professional medical advice.